IX-2000 series (Ionix)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIX-2000 series (Ionix)
Drug Alias NameCav 2.2 antagonist (Ionix)IX-2100IX-2300IX-2200IP-02
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated N-type calcium channel alpha-1B subunit blockers
TargetsVoltage-gated N-type calcium channel alpha-1B subunit
Therapy Area/IndicationsPainUrinary IncontinenceNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIonix Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIonix Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsPainUrinary IncontinenceNeuralgia

Other Information

ATC CodeN/A
Related LinksN/A